pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

28,909 catalysts · 9,438 approval · 5,000 device 510k · 4,728 grant · 2,952 8k filing · 2,000 device pma · 2,000 device recall

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 0 catalysts2026-08-04: 0 catalysts2026-08-05: 0 catalysts2026-08-06: 164 catalysts2026-08-07: 2 catalysts2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 6 catalysts2026-08-11: 4 catalysts2026-08-12: 8 catalysts2026-08-13: 6 catalysts2026-08-14: 1 catalyst2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 2 catalysts2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 1 catalyst2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 5 catalysts2026-10-28: 6 catalysts2026-10-29: 13 catalysts2026-10-30: 3 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2017-11-21×clear all
type
  • approval9,438
  • device 510k5,000
  • grant4,728
  • 8k filing2,952
  • device pma2,000
  • device recall2,000
recall
1,126
  • device adverse event1,000
  • earnings402
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Dec 2, 2019

    8
    ›Dec 6, 2019approval2436d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Dec 6, 2019approval2436d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: AUROBINDO PHARMA. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Dec 6, 2019approval2436d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: AUROBINDO PHARMA. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Dec 6, 2019approval2436d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: AUROBINDO PHARMA. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Dec 6, 2019approval2436d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: AUROBINDO PHARMA. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Dec 6, 2019approval2436d agoMONTELUKAST SODIUM — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 6, 2019approval2436d agoMONTELUKAST SODIUM — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 6, 2019approval2436d agoMONTELUKAST SODIUM — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗

    Week of Dec 9, 2019

    20
    ›Dec 9, 2019approval2433d agoVALPROIC ACID — FDA approvalVALPROIC ACID

    Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL

    full page →VALPROIC ACID →fda approvals ↗
    ›Dec 9, 2019approval

    Week of Dec 16, 2019

    16
    ›Dec 16, 2019approval2426d agoXTANDI (ENZALUTAMIDE) — FDA approvalenzalutamide

    Sponsor: ASTELLAS. Form: CAPSULE. Route: ORAL

    full page →enzalutamide →fda approvals ↗
    ›Dec 16, 2019approval

    Week of Dec 23, 2019

    6
    ›Dec 23, 2019approval2419d agoDEPO-SUBQ PROVERA 104 (MEDROXYPROGESTERONE ACETATE) — FDA approvalmedroxyprogesterone acetate

    Sponsor: PFIZER. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →medroxyprogesterone acetate →fda approvals ↗
    ›Dec 23, 2019approval
    ← prev
    page 33 of 579
    next →
    2433d ago
    VALPROIC ACID — FDA approvalVALPROIC ACID

    Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL

    full page →VALPROIC ACID →fda approvals ↗
    ›Dec 9, 2019approval2433d agoVALPROIC ACID — FDA approvalVALPROIC ACID

    Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL

    full page →VALPROIC ACID →fda approvals ↗
    ›Dec 9, 2019approval2433d agoVALPROIC ACID — FDA approvalVALPROIC ACID

    Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL

    full page →VALPROIC ACID →fda approvals ↗
    ›Dec 9, 2019approval2433d agoVALPROIC ACID — FDA approvalVALPROIC ACID

    Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL

    full page →VALPROIC ACID →fda approvals ↗
    ›Dec 9, 2019approval2433d agoNAPROXEN SODIUM — FDA approvalNAPROXEN SODIUM

    Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL

    full page →NAPROXEN SODIUM →fda approvals ↗
    ›Dec 10, 2019approval2432d agoVALTREX (VALACYCLOVIR HYDROCHLORIDE) — FDA approvalVALACYCLOVIR HYDROCHLORIDE

    Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL

    full page →VALACYCLOVIR HYDROCHLORIDE →fda approvals ↗
    ›Dec 10, 2019approval2432d agoFORFIVO XL (BUPROPION HYDROCHLORIDE) — FDA approvalTWi Pharmaceuticals Inc

    Sponsor: TWI PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Dec 11, 2019approval2431d agoFLUOROURACIL — FDA approvalExtrovis AG

    Sponsor: NOVAST LABS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Dec 12, 2019approval2430d agoXELJANZ XR (TOFACITINIB CITRATE) — FDA approvaltofacitinib citrate ER

    Sponsor: PFIZER. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →tofacitinib citrate ER →fda approvals ↗
    ›Dec 12, 2019approval2430d agoXELJANZ (TOFACITINIB CITRATE) — FDA approvalBiocon Pharma Ltd

    Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 12, 2019approval2430d agoDIVIGEL (ESTRADIOL) — FDA approvalVertical Pharmaceuticals LLC

    Sponsor: VERTICAL PHARMS. Form: GEL. Route: TRANSDERMAL

    full page →fda approvals ↗
    ›Dec 12, 2019approval2430d agoDIVIGEL (ESTRADIOL) — FDA approvalVertical Pharmaceuticals LLC

    Sponsor: VERTICAL PHARMS. Form: GEL. Route: TRANSDERMAL

    full page →fda approvals ↗
    ›Dec 12, 2019approval2430d agoFLUOROURACIL — FDA approvalExtrovis AG

    Sponsor: NOVAST LABS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Dec 12, 2019approval2430d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: ACCORD HLTHCARE. Form: INJECTABLE. Route: INTRAVENOUS

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Dec 12, 2019approval2430d agoPUR-WASH (PURIFIED WATER) — FDA approval

    Sponsor: NIAGARA PHARMS. Form: SOLUTION. Route: OPHTHALMIC

    full page →fda approvals ↗
    ›Dec 13, 2019approval2429d agoCABERGOLINE — FDA approvalCABERGOLINE

    Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL

    full page →CABERGOLINE →fda approvals ↗
    ›Dec 13, 2019approval2429d agoCETIRIZINE HYDROCHLORIDE ALLERGY (CETIRIZINE HYDROCHLORIDE) — FDA approvalCETIRIZINE HYDROCHLORIDE

    Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL

    full page →CETIRIZINE HYDROCHLORIDE →fda approvals ↗
    ›Dec 13, 2019approval2429d agoLEVORPHANOL TARTRATE — FDA approvalLEVORPHANOL TARTRATE

    Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL

    full page →LEVORPHANOL TARTRATE →fda approvals ↗
    ›Dec 13, 2019approval2429d agoCABERGOLINE — FDA approvalCABERGOLINE

    Sponsor: INGENUS PHARMS LLC. Form: TABLET. Route: ORAL

    full page →CABERGOLINE →fda approvals ↗
    2426d ago
    CLEOCIN T (CLINDAMYCIN PHOSPHATE) — FDA approvalCLEOCIN

    Sponsor: PFIZER. Form: GEL. Route: TOPICAL

    full page →CLEOCIN →fda approvals ↗
    ›Dec 16, 2019approval2426d agoCLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approvalCLEOCIN

    Sponsor: PFIZER. Form: SWAB. Route: TOPICAL

    full page →CLEOCIN →fda approvals ↗
    ›Dec 16, 2019approval2426d agoCLEOCIN T (CLINDAMYCIN PHOSPHATE) — FDA approvalCLEOCIN

    Sponsor: PFIZER. Form: LOTION. Route: TOPICAL

    full page →CLEOCIN →fda approvals ↗
    ›Dec 17, 2019approval2425d agoRYTARY (CARBIDOPA) — FDA approvalOrganon & Co.

    Sponsor: IMPAX. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Dec 17, 2019approval2425d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: AVET LIFESCIENCES. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Dec 17, 2019approval2425d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: APOTEX. Form: INJECTABLE. Route: INTRAVENOUS

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Dec 17, 2019approval2425d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: ALEMBIC. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Dec 17, 2019approval2425d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: ALEMBIC. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Dec 17, 2019approval2425d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: ALEMBIC. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Dec 18, 2019approval2424d agoPADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approvalenfortumab vedotin

    Sponsor: ASTELLAS. Form: INJECTABLE. Route: INJECTION

    full page →enfortumab vedotin →fda approvals ↗
    ›Dec 19, 2019approval2423d agoALVIMOPAN — FDA approvalPar Pharmaceutical Inc

    Sponsor: WATSON LABS TEVA. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Dec 20, 2019approval2422d agoJUXTAPID (LOMITAPIDE MESYLATE) — FDA approvalChiesi USA Inc

    Sponsor: CHIESI. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Dec 20, 2019approval2422d agoENHERTU (FAM-TRASTUZUMAB DERUXTECAN-NXKI) — FDA approvaltrastuzumab deruxtecan

    Sponsor: DAIICHI SANKYO. Form: INJECTABLE. Route: INJECTION

    full page →trastuzumab deruxtecan →fda approvals ↗
    ›Dec 20, 2019approval2422d agoCAPLYTA (LUMATEPERONE TOSYLATE) — FDA approvallumateperone tosylate

    Sponsor: INTRA-CELLULAR. Form: CAPSULE. Route: ORAL

    full page →lumateperone tosylate →fda approvals ↗
    ›Dec 20, 2019approval2422d agoCAPLYTA (LUMATEPERONE TOSYLATE) — FDA approvallumateperone tosylate

    Sponsor: INTRA-CELLULAR. Form: CAPSULE. Route: ORAL

    full page →lumateperone tosylate →fda approvals ↗
    2419d ago
    DEPO-SUBQ PROVERA 104 (MEDROXYPROGESTERONE ACETATE) — FDA approvalmedroxyprogesterone acetate

    Sponsor: PFIZER. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →medroxyprogesterone acetate →fda approvals ↗
    ›Dec 23, 2019approval2419d agoDEPO-SUBQ PROVERA 104 (MEDROXYPROGESTERONE ACETATE) — FDA approvalmedroxyprogesterone acetate

    Sponsor: PFIZER. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →medroxyprogesterone acetate →fda approvals ↗
    ›Dec 26, 2019approval2416d agoSTAVZOR (VALPROIC ACID) — FDA approvalVALPROIC ACID

    Sponsor: BIONPHARMA. Form: CAPSULE, DELAYED RELEASE. Route: ORAL

    full page →VALPROIC ACID →fda approvals ↗
    ›Dec 26, 2019approval2416d agoZIPRASIDONE MESYLATE — FDA approvalZIPRASIDONE MESYLATE

    Sponsor: GLAND. Form: POWDER. Route: INTRAMUSCULAR

    full page →ZIPRASIDONE MESYLATE →fda approvals ↗
    ›Dec 27, 2019approval2415d agoSYMDEKO (COPACKAGED) (IVACAFTOR) — FDA approvalivacaftor

    Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL

    full page →ivacaftor →fda approvals ↗
    $PFE25.81+1.57%
    $AMRX18.25-1.14%
    $AMRX18.25-1.14%
    $AMRX18.25-1.14%
    $PFE25.81+1.57%
    $PFE25.81+1.57%
    $PFE25.81+1.57%
    $PFE25.81+1.57%
    $PFE25.81+1.57%
    $OGN13.57+0.07%
    $RDY12.14+0.33%
    $PFE25.81+1.57%
    $VERX11.44-3.09%